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BACKGROUND
The Portuguese National Health Examination Survey is developed as a partof the project “Improvement of epidemiological health information tosupport public health decision and management in Portugal. Towardsreduced inequalities, improved health, and bilateral cooperation”, thatbenefits from a 1.500.000€ Grant from Iceland, Liechtenstein and Norwaythrough the EEA Grants.
FUNDING
High cholesterol level is a major risk factor forcardiovascular disease, responsible for 4.4 milliondeaths per year worldwide [1].According to the WHO, in 2008 prevalence ofelevated total cholesterol among adults inEuropean region was 54% [2].This study aims to estimate the prevalence ofelevated cholesterol in the Portuguese populationbased on the direct measurement of total serumcholesterol.
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Figure 1. Prevalence of elevated total cholesterol by sex and age group
METHODS
Study design: the Portuguese National HealthExamination Survey (INSEF) is a cross-sectionalpopulation-based study.Target population: individuals aged between 25and 74, living in Portugal for more than 12months, non-institutionalized and able to follow aninterview in Portuguese.Sampling: two-stage stratified cluster sampling,with selection of geographical areas in the firststage and individuals in the second stage. In thefirst stage the sample was stratified by region andtypology of urban area.Sample size: n=4911Fieldwork: February 2015 – December 2015The survey encompasses three components:
The overall prevalence of EC was 63.3%.[CI95%: 61.2%-65.4%].  After adjustment for confounding, prevalence ofEC was twice as high among groups aged 55-64and 65-74 compared with age 25-34. No significant differences were observedaccording to sex, level of education oremployment status. 19.3% of the study participants reported takinglipid-lowering medication.
Measurement: Serum from participants’ bloodsamples was used for total cholesterol measuring,using the enzymatic method in accordance withinternational quality standards.Definition: Elevated cholesterol (EC) was definedas having a total serum cholesterol concentrationabove 190 mg/dL (current Portugueserecommendation for treatment) or reporting takinglipid-lowering medication.Statistical analysis: EC estimated prevalence wasstratified by sex, age, level of education andemployment status.Adjusted prevalence ratios were estimated usingPoisson regression.
 Results from the Portuguese National HealthExamination survey in 2015 showed that 63.3%of the population aged between 25-74 years hadtotal cholesterol above the desirable level. Prevalence of elevated cholesterol increasedwith age. Among those under treatment, almost half wasnot controlled. Although the total cholesterol level should beevaluated considering other cardiovascular riskfactors, lowering cholesterol levels may contributeto reducing the burden of cardiovascular diseasein Portugal.
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Figure 2. Prevalence of elevated total cholesterol by level of education and employment  status
 Prevalence of EC was similar for males andfemales. Prevalence of EC increased with age, from38.4% for 25-34 age group to 80.1% for 55-64age group.  Within this treated population, the proportion ofindividuals under control was 56.7%. 3.4% of individuals taking lipid-loweringmedication still had total cholesterol level above270 mg/dL.
 Prevalence of EC was higher for individuals withbasic education, unemployed and with otheremployment status.
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Figure 4. Total cholesterol level among those using lipid lowering medication
Figure 3. Adjusted Prevalence ratios of elevated total cholesterol by  sex, age group, level of education and employment  status
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